Desert_Power
Footballguy
Market not liking the PSTH deal. I wouldn't either.
It poked, but then dropped. Im stillReally disappointed in the paper hands SNDL non-hodlers
@Bob SacamanoFive more quarters like that and I might be back too even.
Am I chopped liver because I was traveling today? What about Bob is fine and all, but what about me? Yes, I should have bought DOCU when it was staring at me in the $60s, but MDB had a nice day. It’s now my second biggest holding behind AMZN. I sold more ZM and TTD, but it’s #2 now.
- It gets approved in the interim and skyrockets so you miss out on the larger gainsSo you like HGEN, Todem recommendation, things looking up...
You want to own more shares and you're ready to pull the trigger on 1000 shares at $18. ... $18,000
... But wait, let me ask you this...
Why not sell 10 $17.50 puts, Jul 16 strike date, that is paying you $2.60 per share...
This gives you $2600 immediately ..
If the price doesn't fall to $17.50, free money. $2600. Take it and buy some shares ... Or sell puts again.
If the price DOES drop below$17.50, the shares are put to you and your cost basis is $14.90 ($17.50 less $2.60)
...vs the $18 cost basis that you would have been sitting on had you just bought the stock.
Todem is on HGEN? Did I miss a post?So you like HGEN, Todem recommendation, things looking up...
Is this the same strategy that made you a board member of NERV?So you like HGEN, Todem recommendation, things looking up...
You want to own more shares and you're ready to pull the trigger on 1000 shares at $18. ... $18,000
... But wait, let me ask you this...
Why not sell 10 $17.50 puts, Jul 16 strike date, that is paying you $2.60 per share...
This gives you $2600 immediately ..
If the price doesn't fall to $17.50, free money. $2600. Take it and buy some shares ... Or sell puts again.
If the price DOES drop below$17.50, the shares are put to you and your cost basis is $14.90 ($17.50 less $2.60)
...vs the $18 cost basis that you would have been sitting on had you just bought the stock.
IDK - all of the CNBC talk of naked shorts has me thinking that the Ape Community has just been given even more fuel and both AMC and GME could squeeze sooner and harder than expected. Of course, I could be completely wrong as well bu I do not see the capacity for WSB to take on too many more children until AMC and GME pop off. Of course, after that, who know there they go and if you beat them there..................I know a lot but of guys here made big money on BNGO. I was late to the party, sold $11 puts, got the shares put to me, and sold at a big loss around $8. Watched it die to $5. Told myself to push all my chips in and load up at $5. Was scared it would drop further, so didn’t. It’s now just above $7 and is getting reddit WSB attention. I think I’m going to buy $50,000 worth on Monday morning and hopefully retire early. Good plan?
I don't think that's wise on this stock. Two outcomes...So you like HGEN, Todem recommendation, things looking up...
You want to own more shares and you're ready to pull the trigger on 1000 shares at $18. ... $18,000
... But wait, let me ask you this...
Why not sell 10 $17.50 puts, Jul 16 strike date, that is paying you $2.60 per share...
This gives you $2600 immediately ..
If the price doesn't fall to $17.50, free money. $2600. Take it and buy some shares ... Or sell puts again.
If the price DOES drop below$17.50, the shares are put to you and your cost basis is $14.90 ($17.50 less $2.60)
...vs the $18 cost basis that you would have been sitting on had you just bought the stock.
Sounds similar to teledoc. (And another favorite). I'll gladly take sustainable growth over current profit in most companies (I'll keep some value too)Bob Sacamano said:No. My wife only lets us cuddle.
(blews out)
To start, I'm a fan of nouns that become verbs. It doesn't have to be ubiquitous, as long as it happens in the right corners of the world. When people around my office started saying, "Docusign it", that got my attention. I started following the company and the stock, eventually buying at price points I liked.
My expectation was that this was going to be a very long term play. They were growing revenue 30+%, and they have 70% of the Esignature market, which is only going to grow. And then Covid hit. Very long-term accelerated into, "Oh, ####, do I hang onto this?" Sure, the smart play would have been to sell at $290 and buy back sub-$200 (The pop to $290 didn't even happen because of their earnings, amusingly, but was a reaction to ZM earnings iirc).
But along the way, I've been listening to earnings calls, watching management, listening to what they're doing, etc. I want to own this company long-term. What's reinforced my belief and expectations is that they're no longer just an esignature company. They're a contract/document lifecycle company. And they're very sticky. Once you have a contract process and repository that's working inside a large corporation, how likely are you to leave it to transition to something else (see 125% NRR posted above)?
They also purchased a small company with (what seems like) a fantastic AI tool that reviews contracts and flags terms, conditions, phrases, etc for further review, exceptions to policy, etc. It's supposed to save substantial time ($$) in legal review. This is in its infant stages. I'm curious to see how this plays out for them in reality. I love the idea of it, but can they make money off of it?![]()
So, I've been watching through Covid. I like their management team. They're taking the AMZN approach. They don't care if people don't like that they're losing money right now. They could be profitable, but they're reinvesting into the business, this quarter be damned. And coming out of Covid, when the stay-at-home stocks are supposed to start floundering, revenue growth is continuing to accelerate. That won't last forever, but I'll wait and see how it plays out.
Finally, I default back to what I said to BnB. My basis is low. It's easy for me to watch and wait. If this dumps 25%, I'm still OK. For people looking at it today, DOCU is NOT cheap. But I still think there's money to be made, even if it doesn't come in the form of![]()
tl; dr
Cool, so I did buy a few shares after all.HGEN was added to the Russell micro cap index yesterday too.
It seems to have a difficult time holding 230. I'd be shocked if a single day 20% pop holds past Tues or Weds without a bit of a pullback. I'd watch for a few days next week.Sounds similar to teledoc. (And another favorite). I'll gladly take sustainable growth over current profit in most companies (I'll keep some value too)
I was putting off adding DocuSign but I think it may be like putting off apple.
My comment was more due to my own reluctance to buy apple. Not that DocuSign is the next apple (it's not). It could very easily be the next brand name that everyone associates with the product or action. Like xerox, Kleenex, Google, etc. But we don't use the product as often as those.And it's WAY too early to think of them like AAPL. Let's get 1/10 of the way there, and I'll be pretty pleased.
I misspoke. Todem did not list HGEN.Todem is on HGEN? Did I miss a post?
1. Guarantees you 14% in 5 weeks.I don't think that's wise on this stock. Two outcomes...
1. EUA approval and you are looking at $28. $10000 - $2600 = $7400 lost.
2. No EUA and you are looking at sub $10. $2600 savings buying the puts.
Quiet period over so here come the $GLBE analyst ratings.$GLBE reported this morning:
Gross Merchandise Volume +133% YOY
Revenue +134%YOY
-Service fees revenue +146%YOY
-Fulfilment revenue +128%YOY
Gross Margin: 29.4% -> 33.3%
Adjusted EBITDA $5.2million (vs. a small loss in Q1’20)
Fiscal Year Revenue Guidance +53-56% YOY
I’ll be adding. Looks like growth might take it on the chin today so I’ll wait and see if it pulls back with everything else. Hasn’t gone parabolic but it has gone from $25 or so to $35 since its IPO. Right now it’s basically even premarket but it’s a small cap.
Anyone still interested in this pig? Im still down 15% and I dont see any horizonLooks like the transition from NGA to LEV is underway.
Up 8.42%. I’ve pounded the table enough on this here now. Would be wise to scale in at this point because it’s not cheap, but this has all the makings of a big long term winner, or SHOP could just buy them.Quiet period over so here come the $GLBE analyst ratings.
Jefferies: PT $44(Buy)
Goldman Sachs: PT $44(Buy)
JMP Securities: PT $43(Outperform)
Piper Sandler: PT $42(Overweight)
KeyBancan: PT $42(Overweight)
Morgan Stanley: PT $42(Overweight)
Raymond James: PT $41(Outperform)
Up 1.4% premarket.
Yeah, ain’t cheap right now. I’m watching as many times IPOs fall into a lull after the initial push up.Up 8.42%. I’ve pounded the table enough on this here now. Would be wise to scale in at this point because it’s not cheap, but this has all the makings of a big long term winner, or SHOP could just buy them.
Speaking of - $UPST lockup expiration is next Thursday according to the NASDAQ site. That might be the pullback you're waiting for to add or for anyone else to start a position. Or it might not be.Yeah, ain’t cheap right now. I’m watching as many times IPOs fall into a lull after the initial push up.
Still upset at myself for UPST. I’d love another pull back, doesn’t have to go to $80 again even 100-120 would be appreciated. It’s done great but I wasn’t expecting that type of pop since it hit the $80s again after earnings.Speaking of - $UPST lockup expiration is next Thursday according to the NASDAQ site. That might be the pullback you're waiting for to add or for anyone else to start a position. Or it might not be.
$GLBE has performed well but hasn't completely exploded. Pullback has to happen but it's not like it went double the IPO price on opening day or anything like a lot of hot IPO's. I think the fact that it's based in Israel might mean it's underfollowed for now. Might change after the analyst barrage today, though.
I'm planning to hold it long-term, but it's a freeroll for me. I got my basis out when it hit $30.Anyone still interested in this pig? Im still down 15% and I dont see any horizon
Today is nice for sure, but this does make me nervous…..Folks, HGEN is good again.
I thought it had some Nader vibes to it as well but somebody said it was scheduled for some reason and he owns like 1.8M shares. So 127k out of that isn’t significant.Today is nice for sure, but this does make me nervous…..
https://www.marketbeat.com/instant-alerts/nasdaq-hgen-insider-buying-and-selling-2021-06/
That is a littleToday is nice for sure, but this does make me nervous…..
https://www.marketbeat.com/instant-alerts/nasdaq-hgen-insider-buying-and-selling-2021-06/
Yes. It's under 3% of the total shares he owns.I thought it had some Nader vibes to it as well but somebody said it was scheduled for some reason and he owns like 1.8M shares. So 127k out of that isn’t significant.
Some other beneficiaries of the FDA approval of Biogen's drug, include mobile infusion companies, those associated with amyloid measurements, such as PET scanning and amyloid tracers, and blood-based biomarkers. Others in the neuroscience discovery business could benefit. But there is a ways to go before insurance companies will reimburse for the Biogen drug. In the Lilly Phase 3 trial, pets scans are given after 24 weeks, and if enough amyloid is removed, dosing stops. Lilly says their drug is better at removing amyloid.LLY having a pretty good day on the back of Biogen's success with their Alzheimer's drug. The barrier for entry may have gotten lowered upon Biogen's approval today as LLY also has an Alzheimer's drug that recently finished a phase 2 trial, Donanemab
I'm going to put more into LLY on next pullback, already have a good amount and with their pipeline, they are a pretty safe play longterm regardless.
Where'd you see that? It doesn't look like it is.somebody said it was scheduled for some reason
DKNG making my day....
Wish the green was more broad-based
But Ill take it
Somebody on Twitter this weekend said it was a prescheduled sale set quite a while ago. I’ll try to find it. And I was wrong, he has 13.5M shares lol. You’d find my ### on an island somewhere.Where'd you see that? It doesn't look like it is.
Your point about % of ownership remains, but according to this it was not scheduled (see 10b5-1 column).Somebody on Twitter this weekend said it was a prescheduled sale set quite a while ago. I’ll try to find it. And I was wrong, he has 13.5M shares lol. You’d find my ### on an island somewhere.
You may be right; I’ll try to find it.Your point about % of ownership remains, but according to this it was not scheduled (see 10b5-1 column).
They also show on fintel, which normally excludes 10b5-1 sales.
He sold an additional 127k (so 200ish total) just 2 days later. No matter how much you own why sell 200k if an event that’s going to spike the price is on the horizon? Scheduled sale would make sense but other then that I’m not sure what else does.You may be right; I’ll try to find it.Your point about % of ownership remains, but according to this it was not scheduled (see 10b5-1 column).
They also show on fintel, which normally excludes 10b5-1 sales.
But why would he sell 75k shares when he owns 13.5 if it wasn’t prescheduled?